 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Talaris Therapeutics, Inc. is a late-clinical stage cell therapy company, which engages in the development of allogeneic hematopoietic stem cell transplantation. The company was founded by Suzanne Ildstad on February 15, 2002 and is headquartered in Wellesley, MA.

Current Price	$2.53
Prev Close	$2.47
Open	$2.50
Dividend Yield	0.00%
50-Day Moving Average	$2.44
Beta	1.44
Avg. Volume	347,272.86
PE Ratio	-1.31

52-Week High	$8.60
52-Week Low	$0.89
Market Capitalization	$104.15M
EPS	-$1.88
Price to Book	0.64
Revenue Per Employee	N/A
Enterprise Value/EBITDA	1.14

TALS Talaris Therapeutics Inc

About

Feed

Fundamentals

News